1997 Earnings Reports from Companies We Own
and
EPS Growth in 1998 of Our Companies Should Handsomely Exceed That of the S&P 500
Over the long term, stock price performance correlates highly with growth in earnings from continuing operations. In that vein, how did earnings from operations progress in the companies we are interested in?
|
Company |
1997 fiscal year |
1996 fiscal year |
1992 fiscal year |
1987 fiscal year |
|
Autodesk |
1.50e |
.95 |
.99 |
.45 |
|
Ballard |
1.04 |
.90 |
.50 |
.04 |
|
Boeing |
.63 |
1.42 |
2.29 |
.69 |
|
Coca Cola |
1.67 |
1.40 |
.72 |
.30 |
|
Enron |
1.98 |
1.82 |
1.05 |
.15 |
|
Gillette |
2.55 |
2.22 |
1.16 |
.50 |
|
H&R Block |
1.65e |
1.13 |
1.68 |
.86 |
|
Ionics |
1.73 |
1.65 |
.93 |
.25 |
|
Lilly |
1.61 |
1.39 |
.72 |
.71 |
|
Mattel |
1.65 |
1.44 |
.71 |
-.62 |
|
Medtronic |
1.3e |
1.12 |
.34 |
.16 |
|
Merck |
3.83 |
3.20 |
2.12 |
.74 |
|
Monsanto |
1.23 |
1.12 |
.56 |
.54 |
|
Nike |
2.04e |
2.69 |
.94 |
.19 |
|
Qualcomm |
1.27 |
.30 |
0 |
na |
|
Sequent |
.92 |
.23 |
.55 |
.20 |
|
St. Jude Med. |
.97 |
1.54 |
1.41 |
.27 |
|
Tupperware |
1.77 |
2.79 |
1.77 |
1.04 |
|
UST |
2.37 |
2.44 |
1.41 |
.56 |
|
Wrigley |
2.36 |
2.10 |
1.27 |
.56 |
"e" means that the company’s fiscal year does not end on December 31, so an estimate of the next fiscal year end results is reported instead. Autodesk’s fiscal year ends on January 31, H&R Block’s on April 30, Medtronic’s and Nike’s on May 31.
Exceptional growth in 1997 earnings per share was reported by Autodesk, H&R Block, Qualcomm, and Sequent, and three of four of these companies’ stocks were exceptional performers in 1997.
Big 1997 disappointments were reported by Boeing, Nike, St. Jude Medical, and Tupperware. This precipitated significant declines in these four stocks, and they are great buys right now if historical long-term growth is restored. Our expectation is that a significant acceleration of growth is imminent at St. Jude, to be followed at Boeing in the second half of 1998, and by Nike and Tupperware in 1999.
Looking at next couple of years, Autodesk, Boeing, H&R Block, Qualcomm, Sequent, and St. Jude Medical are projected to have unusually strong earnings growth. Stock price performance compared to market averages over this period should reflect this. Coke, Gillette, Mattel, Merck, Wrigley and Ballard should continue their usual exceptionally consistent long-term earnings growth.
In summary, I expect the stocks in our portfolios to significantly outperform the broad market averages in 1998, because the earnings growth rates of our companies will significantly outperform that of the average American company.
Steven L. Re¢ , CFA
February 13, 1998